Comparing 4 approaches for high grade glioma
Explore this study →
There are 4 groups in this study. Group A receives Lorlatinib. Group B receives Lorlatinib, together with one or more of: Lorlatinib with chemotherapy1. Group C receives Lorlatinib, together with one or more of: Lorlatinib with chemotherapy 2. …and 1 more groups.
Sites in Montreal and Toronto
- Early Phase 1
- 4 groups
- Sites in Toronto and Montreal
- Recruiting
Official title: Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
High Grade Glioma · Nationwide Children's Hospital